(Q41604026)

4 October 2017

1 reference

title

Adverse cutaneous reactions to psychotropic drugs (English)

1 reference

4 October 2017

MacMorran WS

1

1 reference

PubMed ID

9314710

4 October 2017

Krahn LE

series ordinal

2

1 reference

4 October 2017

1 September 1997

1 reference

4 October 2017

1 reference

4 October 2017

38

1 reference

4 October 2017

5

1 reference

4 October 2017

413-422

1 reference

Rates of cutaneous reactions to drugs. A report from the Boston Collaborative Drug Surveillance Program

4 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

A Review and Controlled Study of Cutaneous Conditions associated with Lithium Carbonate

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Hair loss following lithium therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

1 reference

7 January 2021

Clinically significant side effects of lithium treatment. A survey of 237 patients in long-term treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Serum anticonvulsant concentrations and the risk of drug induced skin eruptions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Hematological effects of carbamazepine in patients with affective illness

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Adverse reactions to carbamazepine managed by desensitisation.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Pigmentation Due to Phenothiazines in High and Prolonged Dosage

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Neuroleptic-induced skin pigmentation in chronic hospitalized schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Resolution of chlorpromazine-induced pigmentation with haloperidol substitution

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Resolution of chlorpromazine-induced cutaneous pigmentation following substitution with levomepromazine or other neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

In Vitro Studies on Longwave Ultraviolet Light-Dependent Reactions of the Skin Photosensitizer Chlorpromazine with Nucleic Acids, Purines and Pyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Angio-oedema associated with risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Adverse cutaneous reactions to antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Treating bulimia with desipramine. A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Allergy to tartrazine in antidepressants.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Drug eruption secondary to trazodone: A recently introduced antidepressant

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

The specificity of the zimelidine reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

A case of fluoxetine-induced serum sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Adverse effects of antianxiety drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

The role of diazepam in skin hyperpigmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Biochemical genetics of neurologic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

The self-inflicted dermatoses: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Phrenotropic drugs in psychosomatic disorders (skin)

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Clinical experience with pimozide: Emphasis on its use in postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Frequency, severity and risk factors for adverse drug reactions in adult out-patients: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Ethnic differences in drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Severe Cutaneous Drug Reactions (Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis) in Human Immunodeficiency Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Rash with amoxycillin-clavulanate therapy in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Bullous skin eruption associated with carbamazepine overdosage

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

Dermatologic adverse drug reactions in a family medicine setting

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

New drugs of the year

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2897%2971418-X

7 January 2021

10.1016/S0033-3182(97)71418-X

Identifiers

DOI

0 references

PubMed ID

9314710

1 reference

PubMed ID

9314710